Dr. Sentana is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
450 Brookline Ave
Boston, MA 02215
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2018 - 2021
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2018
Certifications & Licensure
MA State Medical License 2018 - 2025
Publications & Presentations
PubMed
- 13 citationsexon 20 insertion mutations andmutations in lung cancer: a narrative review on approved targeted therapies from oral kinase inhibitors to antibody-drug conjugates.Daniel Sentana-Lledo, Emmeline Academia, Hollis Viray, Deepa Rangachari, Susumu S Kobayashi
Translational Lung Cancer Research. 2023-07-31 - 13 citationsHCF1 and OCT2 Cooperate with EBNA1 To Enhance OriP-Dependent Transcription and Episome Maintenance of Latent Epstein-Barr VirusJayaraju Dheekollu, Andreas Wiedmer, Daniel Sentana-Lledo, Joel Cassel, Troy E. Messick
Journal of Virology. 2016-06-01 - 1 citationsPatient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).Daniel Sentana-Lledo, Xiangying Chu, David F Jarrard, Michael A Carducci, Robert S DiPaola
European Urology Oncology. 2024-04-29
Press Mentions
Analyzing Quality of Life and Survival from CHAARTED Prostate Cancer Trial - Daniel Sentana LledoJuly 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
